Literature DB >> 2826605

Factors predictive of cytomegalovirus immune status in pregnant women.

B F Walmus1, M D Yow, J W Lester, L Leeds, P K Thompson, R M Woodward.   

Abstract

We performed serological tests for antibody to cytomegalovirus on 1989 pregnant women of middle-to-upper socioeconomic status at the time of their first obstetric visit. Fifty percent of the women had antibody to cytomegalovirus. Analysis with a stepwise logistic regression model revealed that seropositivity was independently correlated with nonwhite race, less than 16 years of education, being breast-fed as an infant, the presence of children five to 18 years of age in the home, and maternal age greater than or equal to 30 years. Conversely, women not possessing these risk factors were more likely to be seronegative; 69% of the women without any of the five factors lacked antibody to cytomegalovirus. Serological screening for antibody would be more useful in obstetric practices where the majority of patients lack these risk factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826605     DOI: 10.1093/infdis/157.1.172

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan.

Authors:  Hamdan Z Hamdan; Ismail E Abdelbagi; Nasser M Nasser; Ishag Adam
Journal:  Virol J       Date:  2011-05-11       Impact factor: 4.099

Review 2.  Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?

Authors:  Richard J Whitley
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

3.  Cytomegalovirus prevalence in pregnant women: the influence of parity.

Authors:  P A Tookey; A E Ades; C S Peckham
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 4.  Pathogenesis of Non-Zika Congenital Viral Infections.

Authors:  Suresh B Boppana; William J Britt; Karen Fowler; S Cecelia Hutto; Scott H James; David W Kimberlin; Claudette Poole; Shannon A Ross; Richard J Whitley
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

5.  Cytomegalovirus infections among African-Americans.

Authors:  Isca R Wilms; Al M Best; Stuart P Adler
Journal:  BMC Infect Dis       Date:  2008-08-01       Impact factor: 3.090

6.  Seroepidemiology Study of Cytomegalovirus and Rubella among Pregnant Women at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Authors:  Mamuye Yeshwondm; Nigatu Balkachew; Bekele Delayehu; Getahun Mekonen
Journal:  Ethiop J Health Sci       Date:  2016-09

7.  Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

Authors:  Gail J Demmler-Harrison; Jerry A Miller
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

8.  Prevention of Primary Cytomegalovirus Infection in Pregnancy.

Authors:  Maria Grazia Revello; Cecilia Tibaldi; Giulia Masuelli; Valentina Frisina; Alessandra Sacchi; Milena Furione; Alessia Arossa; Arsenio Spinillo; Catherine Klersy; Manuela Ceccarelli; Giuseppe Gerna; Tullia Todros
Journal:  EBioMedicine       Date:  2015-08-06       Impact factor: 8.143

9.  Prevalence of CMV infection among sexually active adolescents: a matched case-control study.

Authors:  Michael K Foxworth; Isca R Wilms; Richard R Brookman; Stephanie Crewe; Stuart P Adler
Journal:  Adolesc Health Med Ther       Date:  2014-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.